Zydus Lifesciences Ltd (Including Its Subsidiaries/Affiliates, Hereafter Referred To As "Zydus") Has Received Final Approval From The United States Food And Drug Administration (Usfda) To Manufacture And Market Varenicline Tablets, 0.5 Mg And 1 Mg (Usrld: Chantix
